Skip to content
akaturk Academic measurement

Article detail · 2015 · article

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

ISSN1330-0075
YÖKSİS OpenAlex Open access · gold
Year2015
Citations92OpenAlex
Citations88Semantic Scholar · 4 influential
Percentile%86.4
FWCI2.291.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q4

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueActa Pharmaceutica
  • Catalog match (ISSN)Acta Pharmaceutica
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were prepared for the treatment of painful and inflammatory conditions of the skin. Compritol® 888 ATO, Lanette® O and oleic acid were used as solid and liquid lipids. SLN, NLC and NE were found physically stable at various temperatures for 6 months. Case I diffusional drug release was detected as the dominant mechanism indicating Fickian drug diffusion from nanoparticles and nanoemulsion. The highest rate of drug penetration through rat skin was obtained with NE followed by NLC, SLN and a gel formulation. Nanoformulations significantly increased drug penetration through rat skin compared to the gel (p<0.05). Thus, SLN, NLC and NE of LRX can be suggested for relieving painful and inflammatory conditions of the skin.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

92citationsOpenAlex · cited_by_count (cache / database)

15 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 Loteprednol loaded nanoformulations for corneal delivery: Ex-vivo permeation study, ocular safety assessment and stability studiesCitations 27 · OpenAlex
  2. 2023 Loteprednol loaded nanoformulations for corneal delivery: Ex-vivo permeation study, ocular safety assessment and stability studiesCitations 27 · OpenAlex
  3. 2023 Loteprednol loaded nanoformulations for corneal delivery: Ex-vivo permeation study, ocular safety assessment and stability studiesCitations 27 · OpenAlex
  4. 2023 Loteprednol loaded nanoformulations for corneal delivery: Ex-vivo permeation study, ocular safety assessment and stability studiesCitations 27 · OpenAlex
  5. 2024 Development of Curcumin and Turmerone Loaded Solid Lipid Nanoparticle for Topical Delivery: Optimization, Characterization and Skin Irritation Evaluation with 3D Tissue ModelCitations 21 · OpenAlex
  6. 2024 Development of Curcumin and Turmerone Loaded Solid Lipid Nanoparticle for Topical Delivery: Optimization, Characterization and Skin Irritation Evaluation with 3D Tissue ModelCitations 21 · OpenAlex
  7. 2023 Loteprednol-loaded nanoformulations for corneal delivery by quality-by-design concepts: Optimization, characterization, andaAnti-inflammatory activityCitations 14 · OpenAlex
  8. 2023 Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory ActivityCitations 14 · OpenAlex
  9. 2023 Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory ActivityCitations 14 · OpenAlex
  10. 2024 Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for TherapyCitations 11 · OpenAlex

Authors

5
  1. ÜMİT GÖNÜLLÜ 1
  2. MELİKE ÜNER 2
  3. FATMA GÜLGÜN YENER 3
  4. ECEM FATMA KARAMAN BİRUNİ ÜNİVERSİTESİ 4
  5. ZEYNEP AYDOĞMUŞ 5